Key statistics
On Tuesday, Alterity Therapeutics Ltd (ATHE:NAQ) closed at 1.33, 31.68% above the 52 week low of 1.01 set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.35 |
---|---|
High | 1.35 |
Low | 1.28 |
Bid | 1.20 |
Offer | 1.45 |
Previous close | 1.30 |
Average volume | 11.73k |
---|---|
Shares outstanding | 8.87m |
Free float | 4.75m |
P/E (TTM) | -- |
Market cap | 14.46m USD |
EPS (TTM) | -2.12 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 20:57 BST.
More ▼
Announcements
- Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
- Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
- Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
- Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
- Alterity Therapeutics to Present at MST Financial Webinar
- Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
- Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
- Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
- Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
- Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
More ▼